These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5996675)

  • 1. Deficiencies and hibitors of thromboplastic activity.
    Grannis GF; Kazal LA
    Thromb Diath Haemorrh; 1966 Dec; 16(3):574-85. PubMed ID: 5996675
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Continuous thrombin irrigation for abscessed hematoma in hemophiliac with factor VIII inhibitor.
    Wimer BM
    Thromb Diath Haemorrh; 1975 Dec; 34(3):855-8. PubMed ID: 1209548
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of phospholipid on factor VIII inactivation.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Prog Clin Biol Res; 1984; 150():251-63. PubMed ID: 6431431
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on blood coagulation. I. The influence of AHG concentrate on the activity of antithrombin 3 in normal and hemophilic serum.
    Gang NF; Denstedt OF
    Mt Sinai J Med; 1972; 39(4):352-6. PubMed ID: 4538013
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the study of inhibitor of factor VIII in patients with hemophilia A].
    Papaian-Pokrysheva LP
    Probl Gematol Pereliv Krovi; 1966 Nov; 11(11):46-8. PubMed ID: 6001925
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical aspects of hemophilia].
    Rutberg RA
    Lab Delo; 1977; (3):185-7. PubMed ID: 67277
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor VIII inhibitor and severity of hemophilia.
    Schoppmann A; Waytes AT
    Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.
    Pascual V; Capra JD
    J Clin Invest; 1996 Mar; 97(6):1357-8. PubMed ID: 8617864
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicohaematological profile of two cases of inhibitors to factor VIII.
    Shanthala Devi AM; Srikrishna A; Sitalaksmi S; Damodar P
    Indian J Pathol Microbiol; 2001 Jul; 44(3):365-6. PubMed ID: 12024937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems posed by surgery in a hemophiliac with circulating anticoagulants. Apropos of 3 cases].
    Lareng L; Bierme R; Pris J; Bertrand JC
    Anesth Analg (Paris); 1975; 32(4):623-6. PubMed ID: 1227338
    [No Abstract]   [Full Text] [Related]  

  • 11. [Circulating anticoagulant in hemophilia A: laboratory evidence of a coagulation factor 8 inhibitor].
    Hule V
    Vnitr Lek; 1967 Sep; 13(9):859-65. PubMed ID: 6081657
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring haemophilia severity and treatment: new or old laboratory tests?
    Barrowcliffe TW
    Haemophilia; 2004 Oct; 10 Suppl 4():109-14. PubMed ID: 15479382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF
    Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Appearance of a factor VIII inhibitor during the postoperative period in two non-hemophiliacs].
    Lévy G; Juhan I; Calas-Aillaud MF; Granthil G; Martin C; Verdot JJ; François G
    Ann Anesthesiol Fr; 1980; 21(5):545-9. PubMed ID: 6109504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transient inhibitors developed in two cases of hemophilia A].
    Fujiwara F; Kanoh G; Ogawa H; Takaya K; Hibi S; Shima M; Yoshioka A; Imashuku S
    Rinsho Ketsueki; 1997 Dec; 38(12):1263-8. PubMed ID: 9455145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII inhibitor bypassing activity: a suggested mechanism of action.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Thromb Res; 1981 Jan 1-15; 21(1-2):181-6. PubMed ID: 6785895
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial reconstitution of factor VIII activity from a mild Crm+ hemophilia A patient by replacement of the defective A2 domain.
    Pieneman WC; Fay P; Briët E; Reitsma PH; Bertina RM
    Thromb Haemost; 1998 May; 79(5):943-8. PubMed ID: 9609226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products.
    Briët E; Rosendaal FR; Kreuz W; Rasi V; Peerlinck K; Vermylen J; Ljung R; Rocino A; Addiego J; Lorenzo JI
    Thromb Haemost; 1994 Jul; 72(1):162-4. PubMed ID: 7974368
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between a serum fraction and FEIBA fraction in haemophilia.
    Hutton RA; Dormandy K; Nour-Eldin F
    New Istanbul Contrib Clin Sci; 1980; 13(1):9-22. PubMed ID: 6774316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.